This federal contract award, valued at $1,129.80, was granted by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 9, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA, valued at $999,999,999 and running through November 2026.
The award covers the delivery of COVID-19 vaccines, specifically Pfizer's COVID-19 vaccine, for the 2024-2025 timeframe. The contract is for a 6-month to 4-year period, with an ultimate completion date of December 31, 2024. The contract type is Firm Fixed Price, and there was no set-aside designation used for this award. This contract supports the DLA's role in providing critical medical supplies and pharmaceuticals to military treatment facilities, veterans' healthcare programs, and other federal medical institutions.
Generated 3/16/25, 12:50 AM